Holen Sie sich die Stockscreener-App
2.12
6.00%
0.12
Handel nachbörslich:
2.13
0.010
+0.47%
Finanzdaten der Neumora Therapeutics Inc-Aktie (NMRA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
6.77%
57.70
|
54.04 | 70.94 | 76.65 | 63.82 |
| Operating Income/Loss |
6.77%
-57.70
|
-54.04 | -70.94 | -76.65 | -63.82 |
| Nonoperating Income/Loss |
29.16%
0.945
|
1.334 | 3.049 | 4.152 | 5.247 |
| Income/Loss From Continuing Operations Before Tax |
7.68%
-56.76
|
-52.71 | -67.89 | -72.49 | -58.58 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.025 | 0.105 | 0.053 | 0.125 |
| Income/Loss From Continuing Operations After Tax |
7.63%
-56.76
|
-52.73 | -67.99 | -72.55 | -58.70 |
|
Net Income/Loss
|
7.63%
-56.76
|
-52.73 | -67.99 | -72.55 | -58.70 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.09%
161.84
|
161.69 | 161.45 | 159.58 | 158.98 |
| Diluted Average Shares |
0.09%
161.84
|
161.69 | 161.45 | 159.58 | 158.98 |
| Basic Earnings Per Share |
6.06%
-0.35
|
-0.33 | -0.42 | -0.45 | -0.37 |
| Diluted Earnings Per Share |
6.06%
-0.35
|
-0.33 | -0.42 | -0.45 | -0.37 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):